President of the Republic, Gabriel Boric Font, receives the second shipment of Nirsevimab, a medication to immunize against the respiratory syncytial virus.

Chile Gabriel Boric · President of Chile

21 March 2024 · Reception of the second shipment of Nirsevimab doses

Context
Boric addressed health workers and officials in March 2024 upon receiving 100,000 doses of Nirsevimab, making Chile the first Latin American country to deploy the RSV immunization.
Main themes
Nirsevimab immunization, respiratory syncytial virus prevention, infant health protection, universal health coverage, Chile's regional leadership in healthcare, reduction of hospitalizations, public health logistics, collaboration between health institutions, free vaccination access, winter health preparedness
Duration
~7 min
22nd percentile
Words
790
22nd percentile
Sentences
25
14th percentile
Readability
43
43rd percentile
Grade
15.1
77th percentile
Syntax
3.41
90th percentile
Vocabulary
2.07
20th percentile

Translated from Spanish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 68%68%
  • Ceremonial 20%20%
  • Economic 8%8%
  • Institutional 4%4%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

25 sentences in 17 paragraphs

Thank you very much, Minister.

What an important recognition the Minister makes of the workers. Indeed, a logistics chain that is complex, from here and four other warehouses, as I understand, distributes medications to all of Chile and, therefore, you are part of the Health Network that is fundamental for the care of our people. So, I truly thank you for your work and your vocation.

As the Minister said, it is a joy for us as a Government and for our country the arrival of these 100,000 doses of the medication Nirsevimab, which will be joined by 60,000 more doses that will arrive soon.

This will make it possible for many girls and boys under 6 months old not to become seriously ill from the respiratory syncytial virus. As the Minister told me, nearly 70% of hospitalizations are reduced, at least 70%. In the experience in Spain and the United States, it was even close to 90%.

Chile is the first country in Latin America to acquire this medication and implement this health strategy, which was successfully approved during the winter season in countries in the northern hemisphere. This is not a coincidence; it involves political management, administrative management, professionalism, all the teams from the Ministry of Health and the Ministry of Foreign Affairs working to achieve that we are the first country in Latin America to have this medication.

This immunizes against the syncytial virus and will not only save lives but will also help us reduce the pressure on the Health System that, as the Minister rightly said, we saw in a very critical situation last year.

These doses will be available starting in April in all maternity wards in Chile so that children can receive it immediately upon birth, and it will also be available to families in vaccination centers so that parents of children under 6 months old - and this is important, we ask you to help us convey this message - that is, those born after October 1, 2023, can have this medication for their sons and daughters and thus avoid a serious illness that can cause chronic respiratory problems.

So, starting in April, we invite all parents of children born after October 1 of last year to take them to vaccination centers to receive this medication.

This will be offered free of charge to all infants regardless of their health insurance; it is part of the logic of universal health, of health as a right that we are also applying in this instance.

In the same way, we will maintain coverage for premature children throughout the year. What does this mean? That when the transmission of the virus is reduced, it prevents children from getting sick, and we not only benefit the current generations but also those that come later because there will be fewer chronic illnesses, fewer hospitalizations, and consultations in the future.

This is an important investment, and as the Minister told me, through a study we conducted with the University of Chile, particularly with the Faculty of Engineering and the Faculty of Medicine of the University of Chile, we came to the conviction that these are investments that in the medium term mean savings within our health system.

Therefore, I reiterate the invitation to all parents in our homeland, to all who care for children under 6 months old, to immunize newborns, protecting them from a potentially fatal illness. Last year was very tough regarding the syncytial virus; today, based on the lessons we have learned as a country and from the world, because the outbreak was global, we have the opportunity to face it better.

And that requires the collaboration of everyone, of the distributing companies, of the Public and Private Health Network, and also of the families who are fundamental in the care of our children.

If you have a son or daughter under 6 months old, I insist, starting next April you will be able to take them to the nearest vaccination center to immunize them with this medication, and I ask you to stay tuned to the announcements from the Ministry of Health to follow all the instructions.

Together we can make this winter a better winter and also collaborate with the health workers, who we know have been under a lot of pressure in recent years and we know all that they dedicate themselves to and the effort they make to take care of us.

So, thank you very much to all who work on this, to all who have made this possible, and, of course, to the Ministry of Health, represented by our Minister Ximena Aguilera, our Undersecretary Andrea Albagli, and our Undersecretary Osvaldo Salgado.

A pleasure and thank you very, very much.